BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19090486)

  • 1. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
    J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
    Sivaramakrishnan V; Niranjali Devaraj S
    Chem Biol Interact; 2009 Aug; 180(3):353-9. PubMed ID: 19539802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis.
    Kwon HJ; Won YS; Suh HW; Jeon JH; Shao Y; Yoon SR; Chung JW; Kim TD; Kim HM; Nam KH; Yoon WK; Kim DG; Kim JH; Kim YS; Kim DY; Kim HC; Choi I
    J Immunol; 2010 Oct; 185(7):3980-9. PubMed ID: 20826751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
    Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
    Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
    Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
    Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
    Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
    Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
    Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated IkappaBalpha represses proliferation of immortalized neural progenitor cells and prevents their apoptosis after oxygen-glucose deprivation.
    Zhu C; Liu Z; Gui L; Yao W; Qian W; Zhang C
    Brain Res; 2008 Dec; 1244():24-31. PubMed ID: 18773881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats.
    Dong ZZ; Yao DF; Wu W; Yao M; Yu HB; Shen JJ; Qiu LW; Yao NH; Sai WL; Yang JL
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):169-74. PubMed ID: 20382589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
    Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
    Sakurai T; Maeda S; Chang L; Karin M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice.
    Pasparakis M; Luedde T; Schmidt-Supprian M
    Cell Death Differ; 2006 May; 13(5):861-72. PubMed ID: 16470223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
    Gerondakis S; Grumont R; Gugasyan R; Wong L; Isomura I; Ho W; Banerjee A
    Oncogene; 2006 Oct; 25(51):6781-99. PubMed ID: 17072328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
    Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.